11C-acetate PET/CT in pre-therapeutic lymph node staging in high-risk prostate cancer patients and its influence on disease management - a retrospective study

EJNMMI Research

Table 1 Patient characteristics

	n	Mean	Range
Patients (n)	50
Age (years)		67	41 to 77
PSA (ng/ml)		37	2.7 to 168
Gleason score		8	6 to 10
Estimated risk of locoregional lymph node metastases (%)^a		32	3.3 to 80.3

^aAccording to the Cagiannos pre-treatment nomogram, where age, pre-treatment PSA, clinical tumour stage, primary and secondary Gleason grade, and the number of positive and negative biopsy cores influence the estimated risk.